These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2118430)

  • 41. Expression of protease nexin-1 and plasminogen activators during follicular growth and the periovulatory period in cattle.
    Cao M; Buratini J; Lussier JG; Carrière PD; Price CA
    Reproduction; 2006 Jan; 131(1):125-37. PubMed ID: 16388016
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Secretion of cardiac plasminogen activator during hypoxia-induced right ventricular hypertrophy.
    Bansal DD; Klein RM; Hausmann EH; MacGregor RR
    J Mol Cell Cardiol; 1997 Nov; 29(11):3105-14. PubMed ID: 9405184
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Advanced glycation end products stimulate plasminogen activator activity via GM-CSF in RAW 264.7 cells.
    Saishoji T; Higashi T; Ikeda K; Sano H; Jinnouchi Y; Ogawa M; Horiuchi S
    Biochem Biophys Res Commun; 1995 Dec; 217(1):278-85. PubMed ID: 8526923
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The fibrinolytic activity of staphylokinase mutants in the fibrin plate assay.
    Hauptmann J; Gührs KH; Hartmann M; Schlott B
    Haemostasis; 1995; 25(6):272-6. PubMed ID: 8586317
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The fibrinolytic system in dissemination and matrix protein deposition during a mycobacterium infection.
    Sato J; Schorey J; Ploplis VA; Haalboom E; Krahule L; Castellino FJ
    Am J Pathol; 2003 Aug; 163(2):517-31. PubMed ID: 12875972
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of one-chain and two-chain forms of human tissue-type plasminogen activator by the fast-acting inhibitor of plasminogen activator in vitro and in vivo.
    Colucci M; Paramo JA; Collen D
    J Lab Clin Med; 1986 Jul; 108(1):53-9. PubMed ID: 3086473
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro effects of interleukin 1 on the synthesis of metalloproteases, TIMP, plasminogen activators and inhibitors in human articular cartilage.
    Martel-Pelletier J; Zafarullah M; Kodama S; Pelletier JP
    J Rheumatol Suppl; 1991 Feb; 27():80-4. PubMed ID: 1851231
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A fresh look at the molecular pharmacology of plasminogen activators: from theory to test tube to clinical outcomes.
    Smalling RW
    Am J Health Syst Pharm; 1997 Nov; 54 Suppl 1():S17-22. PubMed ID: 9397233
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urokinase-type plasminogen activator is increased in the involuting ventral prostate of castrated rats.
    Andreasen PA; Kristensen P; Lund LR; Danø K
    Endocrinology; 1990 May; 126(5):2567-76. PubMed ID: 2109689
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Messenger RNA for human tissue plasminogen activator.
    Opdenakker G; Weening H; Collen D; Billiau A; de Somer P
    Eur J Biochem; 1982 Jan; 121(2):269-74. PubMed ID: 7199459
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum.
    Kliem H; Welter H; Kraetzl WD; Steffl M; Meyer HH; Schams D; Berisha B
    Reproduction; 2007 Sep; 134(3):535-47. PubMed ID: 17709571
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nucleotide and deduced amino acid sequences of baboon urokinase-type plasminogen activator.
    Au YP; Wang TW; Clowes AW
    Nucleic Acids Res; 1990 Jun; 18(11):3411. PubMed ID: 2113276
    [No Abstract]   [Full Text] [Related]  

  • 53. Chromosomal locations of human tissue plasminogen activator and urokinase genes.
    Rajput B; Degen SF; Reich E; Waller EK; Axelrod J; Eddy RL; Shows TB
    Science; 1985 Nov; 230(4726):672-4. PubMed ID: 3840278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glucocorticoid modulation of plasminogen activators and of one of their inhibitors in the human mammary carcinoma cell line MDA-MB-231.
    Busso N; Belin D; Failly-Crépin C; Vassalli JD
    Cancer Res; 1987 Jan; 47(2):364-70. PubMed ID: 3098408
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
    Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N
    Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression and localization of extracellular matrix-degrading proteinases and their inhibitors in the bovine mammary gland during development, function, and involution.
    Rabot A; Sinowatz F; Berisha B; Meyer HH; Schams D
    J Dairy Sci; 2007 Feb; 90(2):740-8. PubMed ID: 17235151
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasminogen activator system in osteoclasts.
    Yang JN; Allan EH; Anderson GI; Martin TJ; Minkin C
    J Bone Miner Res; 1997 May; 12(5):761-8. PubMed ID: 9144342
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pemphigus vulgaris and pemphigus foliaceus antibodies are pathogenic in plasminogen activator knockout mice.
    Mahoney MG; Wang ZH; Stanley JR
    J Invest Dermatol; 1999 Jul; 113(1):22-5. PubMed ID: 10417613
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Isolation of cDNA sequences coding for a part of human tissue plasminogen activator.
    Edlund T; Ny T; Rånby M; Hedén LO; Palm G; Holmgren E; Josephson S
    Proc Natl Acad Sci U S A; 1983 Jan; 80(2):349-52. PubMed ID: 6572897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High level expression of human proteins in murine hybridoma cells: induction by methotrexate in the absence of gene amplification.
    Lo KM; Gillies SD
    Biochim Biophys Acta; 1991 Feb; 1088(2):217-24. PubMed ID: 1672095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.